US 7,671,070 B2
Method of treating ophthalmic infections with moxifloxacin compositions
Log In
Please sign up or log in to access the advanced features of
Ex Parte Enterprise.
or Log in

General

US 7,671,070 B2
Method of treating ophthalmic infections with moxifloxacin compositions
Tech Center:
1600 Biotechnology and Organic Chemistry
Examiner:
Zohreh A Fay
Art Unit:
1612 Organic Compounds: Bio-affecting, Body Treating, Drug Delivery, Steroids, Herbicides, Pesticides, Cosmetics, and Drugs
Agent:
Banner & Witcoff. Ltd.
Inventors:
Gerald Cagle; Robert L. Abshire; David W. Stroman; John M. Yanni
Assignee:
NOVARTIS AG
Priority:
09/30/98
Filed:
11/17/03
Granted:
03/02/10
Expiration:
04/04/22
Abstract
Ophthalmic, otic and nasal compositions containing a new class of antibiotics (e.g., moxifloxacin) are disclosed. The compositions preferably also contain one or more anti-inflammatory agents. The compositions may be utilized to treat ophthalmic, otic and nasal conditions by topically applying the compositions to the affected tissues.
Cooperative Patent Classification (CPC)
A61A61K31/5383A61P27/16A61K

Analytics

Cases

Patent Assignments

Citations